Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

403

HTML

3221

Figures (1-1)

243

Tables (1-3)

252

Sum=4119

Publishing Process of This Article

Item

Count

Browse

1532

Download

1252

Sum=2784

Nov 10, 2013 (publication date) through Feb 1, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Obstet Gynecol. Nov 10, 2013; 2(4): 167-175
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.167

Table 2 Postoperative adverse events n (%)

G-CSF: Granulocyte colony-stimulating factor.

Citation: Lotti M, Busci LM, Campanati L, Catena F, Coccolini F, Bakrin N, Iaco PD, Ercolani G, Grosso G, Pisano M, Poiasina E, Rossetti D, Rossi M, Zamagni C, Bertoli P, Pinna AD, Frigerio L, Ansaloni L. Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 167-175
URL: https://www.wjgnet.com/2218-6220/full/v2/i4/167.htm
DOI: https://dx.doi.org/10.5317/wjog.v2.i4.167